Clinical investigations have demonstrated increased levels of serum Ro/SS-A antibodies and rheumatoid factors in individuals with SS.[23] Furthermore, anti-Ro/SS-A and anti-La/SS-B antibodies have been linked to congenital heart block in neonates[24]; however, this correlation has not been substantiated in adult populations. Here, PPIB is linked to congenital heart block.